The Role of Circulating Regulatory T Cell Levels on Subclinical Atherosclerosis and Cardiovascular Risk Factors in Women with Systemic Lupus Erythematosus

Table 1

Baseline characteristics of SLE patients ().

Variable	SLE ()
Age (years), mean ± SD
Framingham score median (IQR)	1.40 (1.40, 2.00%)
BMI (kg/m^2), mean ± SD
Systolic BP (mmHg), mean ± SD
Diastolic BP (mmHg), mean ± SD
Total cholesterol (mg/dl), mean ± SD
Triglycerides (mg/dl), mean ± SD
High-density lipoproteins (mg/dl), mean ± SD
Low-density lipoproteins (mg/dl), mean ± SD
Family history of CVD, (%)	15 (22.7%)
SLE-specific measures
Disease duration (years), mean ± SD
Antiphospholipid syndrome, (%)	6 (9.1)
SLEDAI-2K score, median (IQR)	1.0 (0.0, 4.0)
SLICC damage index, median (IQR)	0.0 (0.0, 1.0)
SLE manifestations, (%)
Mucocutaneous manifestations	43 (65.1)
Articular involvement	41 (62.1)
Renal involvement	21 (31.8)
Hematological involvement	25 (37.8)
Serositis	8 (12.1)
Neuropsychiatric manifestations	0 (0)
Elevated anti-dsDNA antibody^†, (%)	10 (15.2)
Complement C3 (mg/l), mean ± SD
Complement C4 (mg/l), mean ± SD
CVD surrogates
Carotid IMT (mm), mean ± SD

BMI: body mass index; BP: blood pressure; CVD: cardiovascular disease; dsDNA: double-stranded DNA; IMT: intima-media thickness; IQR: interquartile range; SD: standard deviation; SLEDAI-2K: SLE Disease Activity Index 2000; SLICC: Systemic Lupus International Collaborating Clinics. ^†As per laboratory reference range.